|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
Randomized, double-blind, placebo-controlled, parallel group, multi-centre clinical trial to evaluate safety and efficacy of Diclofenac 1% gel vs. placebo gel in patients with acute traumatic blunt soft tissue injury/contusion of the limbs
100 Clinical Results associated with Epifarma Srl
0 Patents (Medical) associated with Epifarma Srl
100 Deals associated with Epifarma Srl
100 Translational Medicine associated with Epifarma Srl